Clinical Trials Directory

Trials / Terminated

TerminatedNCT00796328

Up-Down Determination of the ED90 of Phenylephrine for Hypotension Prophylaxis in Cesarean Delivery

Up-down Determination of the ED90 of the Initial Rate of Infusion of Phenylephrine for the Prophylaxis of Spinal Induced Hypotension in Parturients Undergoing Cesarean Delivery

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
45 (actual)
Sponsor
IWK Health Centre · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

This study is designed to determine the ED90 for an infusion of phenylephrine to prevent spinal induced low blood pressure in parturients presenting for an elective cesarean delivery. The up-down methodology (UDM) is commonly used study method to determine the dose of a drug that causes the desired effect in over 90% of the subjects to whom it given. For example: the investigators want to know what is the best dose of phenylephrine (from a range of commonly used doses) to prevent a drop in blood pressure during cesarean delivery ninety times out of one hundred when it is given at that dose. The ED90 is the effective dose at which 90% of subjects will have a "positive" response to a phenylephrine infusion, i.e. no drop in blood pressure. The investigators hypothesize that the ED90 will be between 40 - 60 mcg/min. The primary outcome measure is the ED90 for phenylephrine infusions that prevents a drop in blood pressure in women undergoing cesarean delivery.

Conditions

Interventions

TypeNameDescription
DRUGPhenylephrine infusionUp-down, biased coin design

Timeline

Start date
2008-11-01
Primary completion
2009-02-01
Completion
2009-07-01
First posted
2008-11-24
Last updated
2018-04-23
Results posted
2014-04-21

Source: ClinicalTrials.gov record NCT00796328. Inclusion in this directory is not an endorsement.